Related Experiment Video
Updated: Aug 14, 2026
Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus
Published on: May 7, 2012
Immunological capacity of human fetal liver cells
1Department of Obstetrics and Gynecology, Karolinska Institute, Huddinge Hospital, Sweden.
Insights
Human fetal liver cells show limited immune responses, making them promising for transplantation. Their low immunological capacity may reduce risks of graft rejection and graft-versus-host disease.
Area of Science:
- Immunology
- Transplantation Biology
- Developmental Biology
Background:
- Human fetal liver (FL) cells are a potential source for cell transplantation.
- Understanding their immunological characteristics is crucial for assessing transplantation safety and efficacy.
- Assessing immune cell function in early developmental stages is key.
Purpose of the Study:
- To evaluate the immunological characteristics of fresh and cryopreserved human fetal liver cells.
- To determine the expression of Human Leukocyte Antigen (HLA) and ABO antigens.
- To assess the responsiveness of FL cells to immune stimuli.
Main Methods:
- Monoclonal antibodies for HLA determinant detection.
- Genomic HLA class II typing using RFLP and PCR.
- Mixed Lymphocyte Culture (MLC) assays.
- Stimulation with mitogens and polyclonal B cell activators.
- ABO antigen determination.
Main Results:
- HLA-associated determinants were demonstrated on FL cells.
- Genomic HLA class II typing was feasible, but serological typing was not.
- Minor responses were observed in MLC.
- FL cells did not show significant DNA synthesis or antibody production upon stimulation.
- ABO antigens were expressed and successfully determined.
Conclusions:
- Human fetal liver cells exhibit a low immunological capacity.
- This reduced immunogenicity suggests a lower risk of graft rejection and graft-versus-host disease.
- FL cells represent a potentially safer option for transplantation therapies.
Abstract:
The aim of this study was to evaluate immunological characteristics of human fetal liver (FL) cells, fresh and cryopreserved, 7-12 weeks post-conception. With monoclonal antibodies, HLA-associated determinants were demonstrated on FL. Although serological HLA determination of A, B, C and class II antigens was not possible, genomic HLA class II typing using RFLP technique or PCR amplification with sequence-specific primers was feasible. MLC induced only minor responses. Exposure to standard mitogens and polyclonal B cell activators did not stimulate DNA synthesis or antibody production. ABO antigens were expressed and determined. The apparent low immunological capacity of FL cells may reduce the risk of rejection and graft-versus-host disease when such cells are used in transplantation.
